AAAAAA
Results: 26-33/33
Authors:
Uekama, K
Citation: K. Uekama, Cyclodextrins in drug delivery system - Preface, ADV DRUG DE, 36(1), 1999, pp. 1-2
Authors:
Irie, T
Uekama, K
Citation: T. Irie et K. Uekama, Cyclodextrins in peptide and protein delivery, ADV DRUG DE, 36(1), 1999, pp. 101-123
Authors:
Hirayama, F
Uekama, K
Citation: F. Hirayama et K. Uekama, Cyclodextrin-based controlled drug release system, ADV DRUG DE, 36(1), 1999, pp. 125-141
Authors:
Okimoto, K
Ohike, A
Ibuki, R
Aoki, O
Ohnishi, N
Rajewski, RA
Stella, VJ
Irie, T
Uekama, K
Citation: K. Okimoto et al., Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent, J CONTR REL, 60(2-3), 1999, pp. 311-319
Authors:
Kimura, K
Hirayama, F
Uekama, K
Citation: K. Kimura et al., Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior, J PHARM SCI, 88(4), 1999, pp. 385-391
Authors:
Hirayama, F
Mieda, S
Miyamoto, Y
Arima, H
Uekama, K
Citation: F. Hirayama et al., Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity, J PHARM SCI, 88(10), 1999, pp. 970-975
Authors:
Miyake, K
Hirayama, F
Uekama, K
Citation: K. Miyake et al., Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrinsin aqueous solution, J PHARM SCI, 88(1), 1999, pp. 39-45
Authors:
Hamano, Y
Ito, K
Matsuda, H
Sumiyoshi, H
Arima, H
Hirayama, F
Uekama, K
Citation: Y. Hamano et al., Inhibitory effect of 2-hydroxypropyl-beta-cyclodextrin on the foaming generated by the phosphodiester compound of vitamin C and E, EPC-K1, CHEM PHARM, 47(6), 1999, pp. 828-832